passages.id: split_6_test_1914_passage
passages.type: progene_text
passages.text: Of the 636 patients , as many as 526 ( 83 % ) had previously or were currently using DMARDs and 98 ( 15 % ) fulfilled both the DMARD and activity criteria , thus being the maximum number of patients considered for TNF - targeted therapy .